title: Late stent thrombosis: considerations and practical advice for the use of drug-eluting stents: a report from the Society for Cardiovascular Angiography and Interventions Drug-eluting Stent Task Force.
authors.affiliation: St. Joseph's Hospital and Medical Center, 350 West Thomas Road, Phoenix, AZ 85013, USA. jhodgson@tsg-ed.com
authors.forename: John McB
authors.initials: JM
authors.lastname: Hodgson
authors.forename: Gregg W
authors.initials: GW
authors.lastname: Stone
authors.forename: A Michael
authors.initials: AM
authors.lastname: Lincoff
authors.forename: Lloyd
authors.initials: L
authors.lastname: Klein
authors.forename: Howard
authors.initials: H
authors.lastname: Walpole
authors.forename: Randy
authors.initials: R
authors.lastname: Bottner
authors.forename: Bonnie H
authors.initials: BH
authors.lastname: Weiner
authors.forename: Martin B
authors.initials: MB
authors.lastname: Leon
authors.forename: Ted
authors.initials: T
authors.lastname: Feldman
authors.forename: Joseph
authors.initials: J
authors.lastname: Babb
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Dehmer
mesh_terms: D026683:Advisory Committees; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects / Q000331:legislation & jurisprudence / Q000592:standards; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D020099:Coated Materials, Biocompatible / Q000592:standards / Q000627:therapeutic use*; D003328:Coronary Thrombosis / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D018579:Patient Selection; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D015607:Stents / Q000009:adverse effects* / Q000592:standards; D013997:Time Factors
chemical_list: D002317:Cardiovascular Agents; D020099:Coated Materials, Biocompatible; D010975:Platelet Aggregation Inhibitors